Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Other Non-Current Liabilities (2022 - 2025)

Senti Biosciences (SNTI) has 4 years of Other Non-Current Liabilities data on record, last reported at $7.6 million in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $7.6 million; the TTM value through Sep 2025 reached $7.6 million, changed N/A, while the annual FY2024 figure was $5.0 million, 20.25% down from the prior year.
  • Other Non-Current Liabilities reached $7.6 million in Q3 2025 per SNTI's latest filing, roughly flat from $7.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $7.6 million in Q2 2025 and bottomed at $20000.0 in Q2 2023.
  • Average Other Non-Current Liabilities over 4 years is $3.8 million, with a median of $4.5 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Liabilities: soared 2688.99% in 2023, then dropped 20.25% in 2024.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $227000.0 in 2022, then skyrocketed by 2688.99% to $6.3 million in 2023, then decreased by 20.25% to $5.0 million in 2024, then skyrocketed by 49.91% to $7.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $7.6 million in Q3 2025, $7.6 million in Q2 2025, and $6.6 million in Q1 2025.